Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary D Novack
Elizabeth D Moyer

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 6, 2015
How Much Nonclinical Safety Data Are Required for a Clinical Study in Ophthalmology?Gary D Novack, Elizabeth D Moyer
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 27, 2018
Slit Lamp-Based Ocular Scoring Systems: CommentaryGary D Novack, Elizabeth D Moyer
The Ocular Surface|April 16, 2013
Where do unused medications go when they die?Gary D Novack, Elizabeth D Moyer
The Ocular Surface|February 23, 2011
The development of drugs vs devicesGary D Novack
The Ocular Surface|February 14, 2009
The "in-between" new drug applicationGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 4, 2015
Eyes on new product developmentGary D Novack
American Journal of Ophthalmology|June 10, 2015
The Importance of A Priori Statistical Planning in Controlled Clinical TrialsGary D Novack
The Ocular Surface|November 1, 2006
Decoding the packaging insert: indicationsGary D Novack
The Ocular Surface|November 30, 2006
What does it mean when a company says that a product is "approvable"?Gary D Novack
The Ocular Surface|November 30, 2006
Is the world flat for pharmaceuticals?Gary D Novack
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 6, 2015
How Much Nonclinical Safety Data Are Required for a Clinical Study in Ophthalmology?Gary D Novack, Elizabeth D Moyer
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 27, 2018
Slit Lamp-Based Ocular Scoring Systems: CommentaryGary D Novack, Elizabeth D Moyer
The Ocular Surface|April 16, 2013
Where do unused medications go when they die?Gary D Novack, Elizabeth D Moyer
The Ocular Surface|February 23, 2011
The development of drugs vs devicesGary D Novack
The Ocular Surface|February 14, 2009
The "in-between" new drug applicationGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 4, 2015
Eyes on new product developmentGary D Novack
American Journal of Ophthalmology|June 10, 2015
The Importance of A Priori Statistical Planning in Controlled Clinical TrialsGary D Novack
The Ocular Surface|November 1, 2006
Decoding the packaging insert: indicationsGary D Novack
The Ocular Surface|November 30, 2006
What does it mean when a company says that a product is "approvable"?Gary D Novack
The Ocular Surface|November 30, 2006
Is the world flat for pharmaceuticals?Gary D Novack
Pageof 31